Home › Trial NCT04175847
A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors
- Trial IDNCT04175847
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorRemeGen Co., Ltd.
- Enrollment198
- Start date2020-04-14
- ConditionsSolid Tumor
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.